S
Shohei Tsuji
Researcher at Saitama Medical University
Publications - 15
Citations - 109
Shohei Tsuji is an academic researcher from Saitama Medical University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 4, co-authored 5 publications receiving 47 citations.
Papers
More filters
Journal ArticleDOI
NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir
Hayato Uemura,Yoshihito Uchida,Jun-ichi Kouyama,Kayoko Naiki,Shohei Tsuji,Kayoko Sugawara,Masamitsu Nakao,Daisuke Motoya,Nobuaki Nakayama,Yukinori Imai,Tomoaki Tomiya,Satoshi Mochida +11 more
TL;DR: GLE/PIB was effective for patients with HCV who failed to achieve an SVR after prior DAA therapies except in those with GT-1b HCV carrying NS5A-P32del even when such strains became undetectable by direct sequencing.
Journal ArticleDOI
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
Yoshihito Uchida,Masamitsu Nakao,Shohei Tsuji,Hayato Uemura,Jun-ichi Kouyama,Kayoko Naiki,Daisuke Motoya,Kayoko Sugawara,Nobuaki Nakayama,Yukinori Imai,Tomoaki Tomiya,Satoshi Mochida +11 more
TL;DR: Switching of the nucleos(t)ide analog used from ETV to TAF may be useful in the treatment of patients with HBV infection, as it is associated with both a decrease in the serum HBsAg level and improvement of the medication compliance.
Journal ArticleDOI
Selection of surrogate viruses for process control in detection of SARS-CoV-2 in wastewater
TL;DR: In this paper , the applicability and limitations of candidate surrogate viruses as process controls under combinations of different virus concentration and RNA extraction methods were evaluated for SARS-CoV-2 spiked in wastewater.
Journal ArticleDOI
Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus
Shohei Tsuji,Yoshihito Uchida,Hayato Uemura,Jun-ichi Kouyama,Kayoko Naiki,Masamitsu Nakao,Daisuke Motoya,Kayoko Sugawara,Nobuaki Nakayama,Yukinori Imai,Tomoaki Tomiya,Satoshi Mochida +11 more
TL;DR: Factors responsible for impaired improvement of liver function despite sustained viral response after direct‐acting antiviral agents therapies in cirrhotic patients with hepatitis C virus need to be elucidated.
Journal ArticleDOI
A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing
Yoshihito Uchida,Jun-ichi Kouyama,Kayoko Naiki,Hayato Uemura,Shohei Tsuji,Kayoko Sugawara,Masamitsu Nakao,Daisuke Motoya,Nobuaki Nakayama,Yukinori Imai,Tomoaki Tomiya,Satoshi Mochida +11 more
TL;DR: The MinION nanopore sequencer is useful for analyzing the HCV genome, especially the genomes of genotype 3 HCV strains for which standardized real‐ time PCR methods for all subgenotypes have not been established.